Tender detail
Open-house discount agreements for medicines containing quinine (ATC M09AA02)
Summary
The procurement concerns non-exclusive discount agreements for medicines containing the active ingredient quinine (ATC M09AA02), under an open-house model. Agreements may be concluded at any time during the period from 1 December 2026 to 30 November 2028. Medicines listed as paediatric medicines under the applicable German medicines rules are excluded.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.